Literature DB >> 20727496

Gene expression of oncogenes, antimicrobial peptides, and cytokines in the development of oral leukoplakia.

M Wenghoefer1, A Pantelis, T Najafi, J Deschner, J P Allam, N Novak, R Reich, M Martini, S Bergé, H P Fischer, S Jepsen, J Winter.   

Abstract

OBJECTIVE: The aim of this study was to investigate the expression pattern of oncogenes, antimicrobial peptides, and genes involved in inflammation in leukoplakia of the oral cavity compared with healthy gingiva. STUDY
DESIGN: Biopsies of healthy gingiva (n=20) and leukoplakia (n=20), were obtained during routine surgical procedures. RNA was extracted according to standard protocols. Transcript levels of alpha-defensin (DEFA) 1/3, DEFA-4, S100-A7, deleted-in-oral-cancer (Doc) 1, interleukin (IL) 1beta, IL-6, IL-8, IL-10, tumor necrosis factor (TNF) alpha, cyclooxygenase (Cox) 2, epidermal growth factor (EGF), keratinocyte growth factor (KGF), transforming growth factor (TGF) beta1, TGF-alpha, collagen-IA1 (Col-1), and tenascin-c were analyzed by real-time reverse-transcription polymerase chain reaction. The proteins encoded by the different genes were visualized by immunostaining.
RESULTS: Compared with healthy gingiva (set as 1), there was an increased gene expression of DEFA-4 (179.2-fold), S100-A7 (25.4-fold), EGF (24.8-fold), TGF-beta1 (25.2-fold), and tenascin-c (34.3-fold) in oral leukoplakia. The expression of IL-1beta and Doc-1 was decreased (0.01-fold and 0.2-fold, respectively).
CONCLUSIONS: The combination of an increased expression of the antimicrobial peptide DEFA-4, the oncogene S100-A7, EGF, and tenascin-c, and a decreased Doc-1 expression in oral leukoplakia might characterize its potency of malignant transformation. Chronic inflammation seems not to be involved in the development of this lesion. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727496     DOI: 10.1016/j.tripleo.2009.08.013

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  11 in total

1.  Oral pathogens change proliferation properties of oral tumor cells by affecting gene expression of human defensins.

Authors:  T Hoppe; D Kraus; N Novak; R Probstmeier; M Frentzen; M Wenghoefer; S Jepsen; J Winter
Journal:  Tumour Biol       Date:  2016-08-01

2.  Oncogenic relevant defensins: expression pattern and proliferation characteristics of human tumor cell lines.

Authors:  Jochen Winter; Dominik Kraus; Jan Reckenbeil; Rainer Probstmeier
Journal:  Tumour Biol       Date:  2015-12-28

3.  Dyskeratosis Congenita Dermal Fibroblasts are Defective in Supporting the Clonogenic Growth of Epidermal Keratinocytes.

Authors:  Erin M Buckingham; Frederick D Goldman; Aloysius J Klingelhutz
Journal:  Aging Dis       Date:  2012-10-12       Impact factor: 6.745

4.  Impairment of mesenchymal stem cells derived from oral leukoplakia.

Authors:  Zhihui Zhang; Jiangyuan Song; Ying Han; Dongdong Mu; Sha Su; Xiaoli Ji; Hongwei Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.

Authors:  Jochen Winter; Annette Pantelis; Dominik Kraus; Jan Reckenbeil; Rudolf Reich; Soeren Jepsen; Hans-Peter Fischer; Jean-Pierre Allam; Natalija Novak; Matthias Wenghoefer
Journal:  BMC Cancer       Date:  2012-10-11       Impact factor: 4.430

6.  Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma.

Authors:  Marina Mohd Bakri; Haizal Mohd Hussaini; Ann Rachel Holmes; Richard David Cannon; Alison Mary Rich
Journal:  J Oral Microbiol       Date:  2010-12-21       Impact factor: 5.474

7.  Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma.

Authors:  Alexandra Fullár; Ilona Kovalszky; Mario Bitsche; Angela Romani; Volker Hans Schartinger; Georg Mathias Sprinzl; Herbert Riechelmann; József Dudás
Journal:  Exp Cell Res       Date:  2012-04-01       Impact factor: 3.905

Review 8.  Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies.

Authors:  Lucía Melguizo-Rodríguez; Victor J Costela-Ruiz; Francisco Javier Manzano-Moreno; Concepción Ruiz; Rebeca Illescas-Montes
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

9.  Genetic polymorphisms and protein levels in vocal fold leukoplakia: a systematic review.

Authors:  C P Campello; M F B Lima-Silva; E L S de Lima; G R S Nunes; H A M Silva; E Dellalibera; L R P B de Britto; C A A Lemos; M T C Muniz
Journal:  Braz J Med Biol Res       Date:  2022-03-11       Impact factor: 2.590

Review 10.  Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.

Authors:  Ruixue Ai; Yan Tao; Yilong Hao; Lu Jiang; Hongxia Dan; Ning Ji; Xin Zeng; Yu Zhou; Qianming Chen
Journal:  Oncotarget       Date:  2017-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.